Skip to main content

Table 2 Recommendations table: symptom management and survivorship

From: Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa

No.

Recommendation

Strength of recommendation

Key references*

General

R1

EB is a disease that is best treated within an IDT that optimally consists of the person living with EB and their carers at the core in addition to a dermatologist, paediatrician/primary care physician, specialist nurse, wound care specialist, surgeon, oncologist, psychologist, pain specialist, palliative care specialist, gastroenterologist, physiotherapist, occupational therapist, and a social worker. Each team member’s role is clearly established shortly after the birth of a baby with EB and are adjusted to meet the child’s evolving needs

↑↑

[8, 9, 11,12,13,14,15,16,17,18,19]

 → [9, 10]

R2

Treatment should focus on achievable goals over the span of an entire lifetime, with the goal of managing physical and/or emotional suffering while respecting the autonomy and individuality of each person, and providing psychoeducation to the person living with EB, their family, and carers in a way they can fully understand

↑↑

[16, 19,20,21]

R5

It is paramount to fully inform the patient of all their treatment options (including no treatment) in an age-appropriate manner and to ensure that all the wishes of the person living with EB and their family are heard and respected, including those related to where they wish to die, the level of sedation that they are willing to tolerate, as well as feeding, and hydration

↑↑

 → [9]

R29

Accurately diagnosing the EB type and applying the appropriate interventions to manage disease complications significantly improves disease management and the likelihood of survival as the patient ages

↑↑

[18, 31]

R30

Consider offering nursing care to give carers respite

[11, 46]

R31

To provide the best possible care, good provider mental health through self-care practices and a life outside of the medical setting is necessary

↑↑

[10, 20, 47, 48]

R32

Parents and their affected child must be allowed the opportunity to voice their opinions regarding the best plan of care

↑↑

[16, 20, 48, 49]

R33

A collaborative “co-survivor” approach between healthcare providers and parents is critical for educating patients on the importance of self-care and for developing better palliative care protocols

GPP

 

R34

A multifactorial approach is recommended to assess the balance between QoL and survivorship

GPP

 

R35

Comorbidities should be diagnosed and treated early whenever possible

↑↑

[54]

Pain and symptom management

R2

See R2 above

↑↑

[16, 19,20,21]

R3

Provide appropriate levels of analgesia to keep pain controlled while using the safest possible routes

↑↑

 → [9]

R6

Steps should always be taken to manage suffering related to pain and itch with the understanding that the aggressiveness of pharmacologic treatment of pain and itch may increase/change as the patient’s goals and clinical trajectory change

↑↑

[20, 27]

R7

Treatment should focus on identifying different pain qualities to plan the most effective and appropriate pharmacologic and non-pharmacologic pain management regimen tailored for the individual and their situation

↑↑

 → [10]

[28,29,30]

Urology

R4

Urinary catheterization and administering nasogastric or subcutaneous fluids toward the end of life may be beneficial if they do not outweigh discomfort and patients at this stage may be more comfortable having fewer or even no dressing changes

GPP

 → [9]

R8

Urological complications should be detected and treated early

↑↑

[31]

Ophthalmology

R9

Ocular involvement, especially management of corneal abrasions and corneal epithelial defects must be considered in all cases of EB

↑↑

[32]

R10

The panel recommends the preventative use of artificial tears to reduce corneal abrasions and to improve eye comfort

GPP

 

Gastroenterology/nutrition

R11

“The aims of nutritional support mainly include:

improving nutritional status,

alleviating the stress of oral feeding, and

minimizing nutritional deficiencies”

↑↑

[2]

R12

Because of the particularly deleterious nature of GER, prompt treatment is necessary

↑↑

[2]

R13

Dietary modifications, such as choosing foods that are energy dense (e.g., fats), softer, and have lower volume, are recommended for strictures that are less severe and esophageal dilation is necessary for severe strictures

↑↑

[2, 34, 35]

R14

Nasogastric tubes are not recommended

↓↓

[2]

R15

G-tube placement is recommended for patients who present with failure to thrive, chronic oral issues, chronic constipation, and/or high stress associated with feeding despite the potential risks

↑↑

[40, 41]

R16

G-tube placement needs to be carefully managed to minimize side effects and potential downstream negative gastrointestinal effects

↑↑

[23, 34]

R17

People affected by more severe forms of EB may need to rely heavily upon increased amounts of micronutrients and vitamins through nutritional supplementation

↑↑

[2]

R18

Infants with more damaged skin may require energy supplementation powders to be added to expressed breast milk/infant formulas so that they may achieve their nutritional goals

↑↑

[2]

R19

Children living with EB may begin consuming solid foods at the same time as unaffected children (i.e., when good head control is achieved), but hard, sharp, or otherwise rough foods are not recommended

↓↓

[2]

R20

Meals should contain the highest caloric and nutrient content with the lowest possible volume

↑↑

[2]

Oral/dental

R21

The importance of good oral preventative care and cautious medication selection is strongly emphasized with the understanding that conventional dental management must typically be modified, and all dental care should, whenever possible, be done by a dentist experienced in the care of people living with EB

↑↑

[34]

R22

Before teeth are extracted, clinicians should consider the difficulties of wearing prosthetic devices as well as the psychological effect losing teeth can have

[34]

R23

Just as a close relationship between the dental care provider and dietitian is important, maximizing prevention methods and utilizing appropriate oral hygiene techniques and equipment are very important

↑↑

[34]

End-of-life

R4

See R4 above

GPP

 → [9]

R24

After a diagnosis of severe JEB subtype is made, it is advisable to focus exclusively on comfort-oriented care

↑↑

[43]

R25

Enteral nutrition is not recommended in the context of severe JEB

↓↓

[2]

R26

Withholding medically non-beneficial interventions is well-established in both adult and paediatric medicine and is widely practiced in end-of-life care for people with EB

GPP

[20]

R27

To relieve refractory symptoms, palliative sedation may be considered

[22]

R28

Providing pain medications with the intent of symptom management is well-established and is an alternative to ethical treatment of pain without resorting to euthanasia, even if doing so hastens death

↑↑

[20]

  1. Recommendations are based on the results of the literature review. In addition, other recommendations relating to palliative care were added during the process of guideline development from expert consensus, and the experience of the guideline development group. To provide easier access to information, the recommendations in this table are grouped in accordance with the clinical questions and are arranged by clinical subheadings. If a recommendation fit within multiple subheadings or within multiple clinical questions, it was listed in each. Recommendations were not listed in order of strength or importance. Recommendation strength was strongly influenced by expert panel decision-making, which accounts for observable gaps between evidence levels and recommendation strength. The evidence level is very low for all recommendations. For the strength of recommendation ratings see Table 1. EB, epidermolysis bullosa; GPP, good practice point; G-tube, gastrostomy feeding tube; JEB, junctional epidermolysis bullosa; IDT, interdisciplinary team; QoL, quality-of-life; RDEB, recessive dystrophic epidermolysis bullosa; SCC, squamous cell carcinoma. *Right-pointing arrows (→) denote a guideline document